How Does CBD Oil Treat Medical Conditions?


CBD (Cannabidiol) is a non-poisonous part of the marijuana plant. It has attracted substantial interest from physicians and scientists recently. However, its' little therapeutic benefits are still being investigated. CBD is classed as a pleiotropic substance because it causes some effects via numerous molecular passageways. Scientific papers have identified over sixty-five CBD molecular targets.

While CBD does not have much binding affinity with the CB2 and CB1 cannabinoid receptors, it modulates various non-cannabinoid ion channels and receptors. Also, CBD functions through several receptor-independent passageways -- for instance, by obstructing endogenous neurotransmitter reuptake (concerning adenosine and anandamide, among others) and by impeding or improving the binding effects of some G protein-linked receptors.

How Does CBD Oil Work


Perhaps surprisingly, CBD doesn't function by attaching to the CBD receptors CB2 or CB1 directly. Instead, it operates through independent receptor passageways - for instance, by influencing the receptors' binding capacity and/or by obstructing neurotransmitter metabolism within the endocannabinoid system.

While we are finding out the precise mechanisms via which CBD functions, there's exciting news on the horizon from recent research in 2019, indicating CBD's different health advantages. To learn more about the numerous ways that CBD works with ECS in the body to improve health, let us examine some of the ideas emerging from the ongoing research:

5-HT1A Receptors

5-HT1A receptors are not well known. However, most people are familiar with serotonin -- which is a neurotransmitter that attaches to them. The way that serotonin and 5-HT1A interacts plays a vital part in mood regulation.

You might know that lots of drugs used to treat depression are intended to actively boost serotonin levels in our bodies, by stopping the body from metabolizing it. This type of medication is called SSRI (Selective Serotonin Reuptake Inhibitors).

CBD engages with 5-HT1A receptors as well, producing fast antidepressant benefits in tests on mice. While additional studies need to be carried out, there's data to indicate that future CBD research might have therapeutic benefits for people who suffer from anxiety and depression, due to this interaction.

Vanilloid (TRPV1) Receptors

TRPV1, or Vanilloid, receptors play a part in body temperature, inflammation response and pain perception. Lots of medicinal plants have compounds in them that engage with this receptor. However, the most well known is the vanilla bean - due to its' eugenol essential oil. Capsaicin -- which is an aromatic chili pepper compound -- triggers the Vanilloid receptor. The endogenous cannabinoid Anandamide does this as well.

For a long time, the TRPV1 receptor has been a pain intervention target. Because CBD attaches itself to TRPV1, it shows potential as a nociceptive inflammation and pain treatment.

CBD engages directly with different ion channels to produce therapeutic benefits. For instance, it attaches to Vanilloid receptors that also serve as ion channels. These receptors are proven to affect inflammation, body temperature and pain perception.

Reuptake Inhibitor Application

How can the external plant compound CBD get into human cells to attach to nuclear receptors? Firstly, it needs to travel through cell membranes by getting a lift from FABP (fatty acid binding proteins), which guide different molecules of lipid into the cells. Also, these intracellular molecules send THC (tetrahydrocannabinol), 2AG and endocannabinoids anandamide (which are cannabis-like molecules in the brain) over the membrane to numerous locations inside the cell. THC and CBD each influence receptors that are on the nucleus surface, which control mitochondrial activity and gene expression. Furthermore, CBD counteracts cancer by triggering PPARs on the cell's nucleus surface.

Cannabidiol has a strong attraction to three types of FABPs, and the fatty acid endocannabinoids compete with CBD for transport molecules. After it enters cells, anandamide is processed by the metabolic enzyme FAAH, during its' normal molecular cycle. However, CBD obstructs this process by cutting down the access that anandamide has to FABP molecules and hindering the passage of endocannabinoid into cells.

The anti-anxiety and anti-inflammatory impact of CBD is partly due to its' obstruction of adenosine reuptake. Because it delays this process, CBD increases the brain's levels of adenosine. In turn, this affects the activity of adenosine receptors. A2A and A1A adenosine receptors have a crucial part to play in aerobic function, controlling coronary blood flow and myocardial oxygen consumption. Throughout the human body, these receptors produce wide-ranging anti-inflammatory effects.

GPR55 Receptors

Ruth Ross, a scientist from Aberdeen University, revealed that CBD is an antagonist of GPR55 at the Swedish 2010 Global Cannabinoid Research Society conference. By obstructing GPR55 signals, CBD might serve to reduce the spreading of cancer cells and bone reabsorption.

While cannabidiol triggers the serotonin 5-HT1A receptor directly, along with many ion TRPV channels, several studies indicate that CBD serves as an obstacle that deactivates, or blocks, another receptor linked to a G protein called GPR55.

The nickname for GPR55 is the 'orphan receptor'. The reason for this is that scientists still don't know whether it is part of a bigger receptor family. GPR55 is expressed widely inside the brain, particularly inside the cerebellum. It's used to modulate bone density and blood pressure, as well as additional physiological processes.

GPR55 facilitates osteoclast cell functionality, which benefits bone reabsorption. Signals from overactive GPR55 receptors have been linked to osteoporosis.

Nuclear Receptors - PPARS

Moreover, CBD has an anti-cancer impact by triggering PPARs (proliferator peroxisome activated receptors), which are located on the cell nucleus surface. Triggering the receptor called PPAR gamma produces an anti-proliferative impact, along with an ability to fight tumors in lung cancer cells. The triggering of PPAR gamma undermines amyloid beta plaque, which is a vital molecule associated with Diabetes and the onset of Alzheimer's. For this reason, cannabidiol, as a PPAR gamma activator, might be an effective treatment for people living with Alzheimer's.

Besides, PPAR receptors control genes which are used in insulin sensitivity, lipid uptake, energy homeostasis, and other metabolic processes. As a result, people with diabetes might find that their condition improves, after undergoing a CBD focused treatment regime. All in all, CBD treatments look highly promising in many ways, and are sure to attract their fair share of media attention in future.


So there we have it, that is how CBD Oil works to treat various medical conditions. For some people this may sound quite complicated but hopefully you can see that there is Scientific research on how the Oil works to help these conditions.

Leave a Reply

Your email address will not be published. Required fields are marked *